Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck’s Solid Quarter Doesn’t Soothe Seagen M&A Watchers
No Deal Was Announced, To The Chagrin Of Investors
Jul 28 2022
•
By
Mandy Jackson
CEO Robert Davis declined to speculate on future transactions • Source: Shutterstock
More from Deals
More from Business